# A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease

> **NCT00225810** · PHASE4 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 50 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** Crohn's Disease

## Key facts

- **NCT ID:** NCT00225810
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2006-02
- **Final completion:** 2006-02
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2011-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00225810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00225810, "A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00225810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*